Literature DB >> 2821617

Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.

D M Ornitz1, R E Hammer, A Messing, R D Palmiter, R L Brinster.   

Abstract

Three lines of transgenic mice were produced that develop pancreatic neoplasms as a consequence of expression of an elastase I-SV40 T-antigen fusion gene in the acinar cells. A developmental analysis suggests at least a two-stage process in the ontogeny of this disease. The first stage is a T antigen-induced, preneoplastic state characterized by a progression from hyperplasia to dysplasia of the exocrine pancreas, by an increased percentage of tetraploid cells, and by an arrest in acinar cell differentiation. The second stage is characterized by the formation of tumor nodules that appear to be monoclonal, because they have discrete aneuploid DNA contents. The cells within the nodules as compared to normal pancreatic tissue have less total RNA by a factor of 5, less pancreas-specific messenger RNA by a factor of about 50, and increased levels of T-antigen messenger RNA. A tumor cell line has been derived that retains both pancreatic and neoplastic properties.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821617     DOI: 10.1126/science.2821617

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  83 in total

1.  Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1.

Authors:  P R Andreassen; O D Lohez; F B Lacroix; R L Margolis
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 2.  Transgenic models of pancreatic cancer.

Authors:  Andrew M Lowy
Journal:  Int J Gastrointest Cancer       Date:  2003

3.  A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase-1 promoter produces pancreatic acinar carcinomas in transgenic mice.

Authors:  M J Tevethia; R H Bonneau; J W Griffith; L Mylin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

5.  The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

Authors:  Brian C Lewis; David S Klimstra; Harold E Varmus
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

6.  Lymphotropic papovavirus early region is specifically regulated transgenic mice and efficiently induces neoplasia.

Authors:  J D Chen; K Neilson; T Van Dyke
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2).

Authors:  G H Swift; Y Liu; S D Rose; L J Bischof; S Steelman; A M Buchberg; C V Wright; R J MacDonald
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  Lack of allelic loss at the multiple endocrine neoplasia type 1 (MEN-1) gene locus in a pancreatic ductal (non-endocrine) adenocarcinoma of a patient with the MEN-1 syndrome.

Authors:  C Bordi; A Falchetti; C Azzoni; T D'Adda; A Morelli; A Peracchia; M L Brandi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Malignant melanoma in transgenic mice.

Authors:  M Bradl; A Klein-Szanto; S Porter; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

10.  Polyomavirus DNA replication in the pancreas and in a transformed pancreas cell line has distinct enhancer requirements.

Authors:  R Rochford; L P Villarreal
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.